Jinhe Biotechnology CO., LTD. (002688.SZ)
CNY 7.18
(9.95%)
CNY 7.18
(9.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 602.51 Million CNY | 4.68% |
| 2022 | 613.79 Million CNY | -5.73% |
| 2021 | 651.06 Million CNY | 3.35% |
| 2020 | 629.94 Million CNY | -3.55% |
| 2019 | 653.12 Million CNY | 5.97% |
| 2018 | 616.32 Million CNY | 10.35% |
| 2017 | 558.5 Million CNY | 9.25% |
| 2016 | 511.21 Million CNY | 41.34% |
| 2015 | 361.7 Million CNY | 39.31% |
| 2014 | 259.63 Million CNY | -1.05% |
| 2013 | 262.38 Million CNY | 5.54% |
| 2012 | 248.62 Million CNY | 2.75% |
| 2011 | 241.95 Million CNY | 30.36% |
| 2010 | 185.6 Million CNY | 56.64% |
| 2009 | 118.49 Million CNY | 21.04% |
| 2008 | 97.89 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 177.35 Million CNY | -0.12% |
| 2024 Q3 | 196.4 Million CNY | 10.74% |
| 2024 Q1 | 177.56 Million CNY | 15.06% |
| 2023 Q2 | 153.48 Million CNY | -1.02% |
| 2023 Q1 | 155.06 Million CNY | 5.73% |
| 2023 FY | 642.49 Million CNY | 4.68% |
| 2023 Q4 | 154.32 Million CNY | -14.08% |
| 2023 Q3 | 179.61 Million CNY | 17.02% |
| 2022 Q4 | 146.66 Million CNY | 1.14% |
| 2022 FY | 613.79 Million CNY | -5.73% |
| 2022 Q3 | 145.01 Million CNY | -11.65% |
| 2022 Q2 | 164.12 Million CNY | 3.89% |
| 2022 Q1 | 157.98 Million CNY | -4.94% |
| 2021 FY | 651.06 Million CNY | 3.35% |
| 2021 Q2 | 146.44 Million CNY | -22.51% |
| 2021 Q3 | 149.44 Million CNY | 2.05% |
| 2021 Q1 | 188.98 Million CNY | 22.4% |
| 2021 Q4 | 166.19 Million CNY | 11.21% |
| 2020 Q2 | 152.74 Million CNY | -7.95% |
| 2020 Q1 | 165.94 Million CNY | 0.54% |
| 2020 Q4 | 154.39 Million CNY | -1.57% |
| 2020 FY | 629.94 Million CNY | -3.55% |
| 2020 Q3 | 156.86 Million CNY | 2.69% |
| 2019 Q2 | 177.43 Million CNY | 6.96% |
| 2019 FY | 653.12 Million CNY | 5.97% |
| 2019 Q4 | 165.04 Million CNY | 14.02% |
| 2019 Q3 | 144.75 Million CNY | -18.42% |
| 2019 Q1 | 165.89 Million CNY | -15.78% |
| 2018 Q2 | 132.57 Million CNY | -1.44% |
| 2018 Q1 | 134.51 Million CNY | -31.21% |
| 2018 Q4 | 196.97 Million CNY | 29.38% |
| 2018 FY | 616.32 Million CNY | 10.35% |
| 2018 Q3 | 152.25 Million CNY | 14.84% |
| 2017 Q4 | 195.54 Million CNY | 73.44% |
| 2017 Q2 | 126.55 Million CNY | 2.34% |
| 2017 FY | 558.5 Million CNY | 9.25% |
| 2017 Q1 | 123.66 Million CNY | -10.99% |
| 2017 Q3 | 112.74 Million CNY | -10.91% |
| 2016 Q4 | 138.93 Million CNY | 6.11% |
| 2016 FY | 511.21 Million CNY | 41.34% |
| 2016 Q3 | 130.92 Million CNY | 6.9% |
| 2016 Q2 | 122.47 Million CNY | 3.03% |
| 2016 Q1 | 118.87 Million CNY | 8.9% |
| 2015 Q2 | 85.03 Million CNY | 18.25% |
| 2015 Q1 | 71.91 Million CNY | -3.89% |
| 2015 FY | 361.7 Million CNY | 39.31% |
| 2015 Q4 | 109.16 Million CNY | 14.21% |
| 2015 Q3 | 95.58 Million CNY | 12.41% |
| 2014 Q4 | 74.82 Million CNY | 43.14% |
| 2014 FY | 259.63 Million CNY | -1.05% |
| 2014 Q2 | 73.77 Million CNY | 25.53% |
| 2014 Q1 | 58.76 Million CNY | -28.86% |
| 2014 Q3 | 52.27 Million CNY | -29.14% |
| 2013 Q3 | 61.19 Million CNY | -6.09% |
| 2013 Q4 | 82.61 Million CNY | 34.99% |
| 2013 FY | 262.38 Million CNY | 5.54% |
| 2013 Q1 | 53.4 Million CNY | -29.03% |
| 2013 Q2 | 65.16 Million CNY | 22.02% |
| 2012 Q2 | 63.69 Million CNY | 7.35% |
| 2012 Q4 | 75.25 Million CNY | 49.48% |
| 2012 Q1 | 59.33 Million CNY | -23.61% |
| 2012 Q3 | 50.34 Million CNY | -20.96% |
| 2012 FY | 248.62 Million CNY | 2.75% |
| 2011 Q4 | 77.66 Million CNY | 105.17% |
| 2011 Q3 | 37.85 Million CNY | 0.0% |
| 2011 FY | 241.95 Million CNY | 30.36% |
| 2010 FY | 185.6 Million CNY | 56.64% |
| 2009 FY | 118.49 Million CNY | 21.04% |
| 2008 FY | 97.89 Million CNY | 0.0% |